Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care.
View the full Corporate Spotlight
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | $1.55 | Day High | $1.56 | Day Low | $1.51 | |||
| Daily Volume | 62251 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 2 | $1.55 | 3015 | 1 | $1.56 | 4018 | |
| Ms. Mary Harney | Non-Executive Chair. |
| Mr. Phillip R. Lynch | Non-Executive Director |
| Prof. Michael Kelso | Principal Scientist |
| Dr. Sophia Moscovis | Program Management, Risk & Strategy Director |
| Dr. Marinella Messina | Clinical Program Director |
| Dr. Daniel Tillett | Chief Executive Officer |
| Mr. Brendan Brown | Chief Financial Officer |
| Prof. Tim Hammond | Interim Chief Scientific Officer |
| Dr. Peter Smith | Executive Director |
| Prof. Borje S. Andersson | Chair – Clinical Advisory Board |
| Dr. Michelle Rashford | Chief Medical Officer |
| Mr. Peter Gordon Webse | Company Secretary |
| Dr. John Cullity | Non-Executive Director |
Data source: Refinitiv
 (20min delay)
|
|||||
|
Last
$1.56 |
Change
0.010(0.65%) |
Mkt cap ! $265.8M | |||
| Open | High | Low | Value | Volume |
| $1.55 | $1.56 | $1.51 | $95.69K | 62.25K |
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3015 | $1.55 |
| Price($) | Vol. | No. |
|---|---|---|
| $1.56 | 4018 | 1 |
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.56 |
Change
0.010 ( 1.42 %) |
||||
| Open | High | Low | Volume | ||
| $1.53 | $1.56 | $1.51 | 10357 | ||
| Last updated 15.54pm 23/08/2024 ? | |||||
| RAC (ASX) Chart |
